Поисковый запрос: (<.>A=Varga, Jozsef$<.>) |
Общее количество найденных документов : 22
Показаны документы с 1 по 20
|
|
1.
| Conformation mapping of amyloid peptides from the putative neurotoxic 25-35 region // Biochem. and Biophys. Res. Commun., 1994. Vol. 205, N 1.-С.120-126
|
2.
| Szisztemas trombolizis es szabadgyokos reakciok human miokardialis infarktusban // Orvoskepzes, 1993. Vol. 68, N 6.-С.421-430
|
3.
| Human renal cell carcinoma expresses distinct binding sites for growth hormoe-releasing hormone // Proc. Nat. Acad. Sci. USA, 2000. Vol. 97, N 19.-С.10555-10560
|
4.
| Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity // Int. J. Cancer, 2002. Vol. 98, N 4.-С.624-629
|
5.
| Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity // Int. J. Cancer, 2002. Vol. 98, N 4.-С.624-629
|
6.
| Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity // Int. J. Cancer, 2002. Vol. 98, N 4.-С.624-629
|
7.
| Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways // Prostate, 2000. Vol. 44, N 2.-С.172-180
|
8.
| Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways // Prostate, 2000. Vol. 44, N 2.-С.172-180
|
9.
| Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide // Prostate, 2001. Vol. 48, N 3.-С.188-199
|
10.
| Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide // Prostate, 2001. Vol. 48, N 3.-С.188-199
|
11.
| {99m}Tc-MIBI SPECT assessment og the effects of aneurysm resection on the left ventricular morphology // Acta cardiol., 2004. Vol. 59, N 5.-С.541-546
|
12.
| MR image-based tissue analysis and its clinical applications // Proc. SPIE, 2002. Vol. 4684.-С.424-432
|
13.
| Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel // Proc. Nat. Acad. Sci. USA, 2006. Vol. 103, N 39.-С.145/3-145/8
|
14.
| Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel // Proc. Nat. Acad. Sci. USA, 2006. Vol. 103, N 39.-С.145/3-145/8
|
15.
| Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and dicrease in p21 and mutant p53 proteins // Prostate, 2012. Vol. 72, N 5.-С.555-565
|
16.
| Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and dicrease in p21 and mutant p53 proteins // Prostate, 2012. Vol. 72, N 5.-С.555-565
|
17.
| Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and dicrease in p21 and mutant p53 proteins // Prostate, 2012. Vol. 72, N 5.-С.555-565
|
18.
| Varga Corontin forte okozta torsades de pointes es kamrafibrillacio // Gyogyszereink, 1990. Vol. 40, N 8.-С.242-244
|
19.
| A bilharziasissal szovodott holyagrak // Orv. hetilap., 1991. Vol. 132, N 4.-С.189-191
|
20.
| A szivizom es az also vegtagok perfuziojanak egyideju vizsgalata terheleses {2}{0}{1}Tl-szcintigrafiaval // Izotoptechn., diagn., 1991. Vol. 34, N 1.-С.3
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"